Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.

Makoto Nishio; Fabrice Barlesi; Fabrice Barlesi; Howard West; Simon Ball; Rodolfo Bordoni; Manuel Cobo; Pascale Dubray Longeras; Jerome Goldschmidt; Silvia Novello; Francisco Orlandi; Rachel E. Sanborn; Zsuzsanna Szalai; Grigoriy Ursol; Diana Mendus; Lijia Wang; Xiaohui Wen; Mark McCleland; Tien Hoang; See Phan; Mark A. Socinski

doi:10.1016/J.JTHO.2020.11.025

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.

Makoto Nishio
, Fabrice Barlesi
, Fabrice Barlesi
, Howard West
, Simon Ball
, Rodolfo Bordoni
, Manuel Cobo
, Pascale Dubray Longeras
, Jerome Goldschmidt
, Silvia Novello
, Francisco Orlandi
, Rachel E. Sanborn
, Zsuzsanna Szalai
, Grigoriy Ursol
, Diana Mendus
, Lijia Wang
, Xiaohui Wen
, Mark McCleland
, Tien Hoang
, See Phan

Mark A. Socinski

Japanese Foundation for Cancer Research
French Institute of Health and Medical Research
Institut Gustave Roussy
City of Hope National Medical Center
The Queen's Medical Center
Northside Hospital
Unidad de Gestión Clínica Intercentros de Oncología Médica. Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain
Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France
Blue Ridge Cancer Care, Blacksburg, Virginia
University of Turin
Department of Medical Oncology, Instituto Nacional del Tόrax, Santiago, Chile
Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon
Department of Pulmonology, Petz Aladár County Teaching Hospital, Vasvári Pál, Hungary
Acinus, Karla Marksa Kirovograd, Ukraine
Genentech
Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, Florida

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Thoracic Oncology
Volume	16
Issue number	4
DOIs	https://doi.org/10.1016/J.JTHO.2020.11.025
State	Published - Apr 1 2021
Externally published	Yes

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1016/J.JTHO.2020.11.025License: Unspecified

Cite this

Nishio, M., Barlesi, F., Barlesi, F., West, H., Ball, S., Bordoni, R., Cobo, M., Longeras, P. D., Goldschmidt, J., Novello, S., Orlandi, F., Sanborn, R. E., Szalai, Z., Ursol, G., Mendus, D., Wang, L., Wen, X., McCleland, M., Hoang, T., ... Socinski, M. A. (2021). Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial. Journal of Thoracic Oncology, 16(4). https://doi.org/10.1016/J.JTHO.2020.11.025

Nishio, M, Barlesi, F, Barlesi, F, West, H, Ball, S, Bordoni, R, Cobo, M, Longeras, PD, Goldschmidt, J, Novello, S, Orlandi, F, Sanborn, RE, Szalai, Z, Ursol, G, Mendus, D, Wang, L, Wen, X, McCleland, M, Hoang, T, Phan, S & Socinski, MA 2021, 'Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.', Journal of Thoracic Oncology, vol. 16, no. 4. https://doi.org/10.1016/J.JTHO.2020.11.025

@article{7bd2149005da4930b841d9194882acf8,

title = "Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.",

author = "Makoto Nishio and Fabrice Barlesi and Fabrice Barlesi and Howard West and Simon Ball and Rodolfo Bordoni and Manuel Cobo and Longeras, \{Pascale Dubray\} and Jerome Goldschmidt and Silvia Novello and Francisco Orlandi and Sanborn, \{Rachel E.\} and Zsuzsanna Szalai and Grigoriy Ursol and Diana Mendus and Lijia Wang and Xiaohui Wen and Mark McCleland and Tien Hoang and See Phan and Socinski, \{Mark A.\}",

note = "INTRODUCTION: We report the final results of the phase 3 IMpower132 study evaluating atezolizumab plus carboplatin or cisplatin plus pemetrexed (APP) in patients with nonsquamous NSCLC.",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/J.JTHO.2020.11.025",

language = "American English",

volume = "16",

journal = "Journal of Thoracic Oncology",

number = "4",

}

TY - JOUR

T1 - Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.

AU - Nishio, Makoto

AU - Barlesi, Fabrice

AU - West, Howard

AU - Ball, Simon

AU - Bordoni, Rodolfo

AU - Cobo, Manuel

AU - Longeras, Pascale Dubray

AU - Goldschmidt, Jerome

AU - Novello, Silvia

AU - Orlandi, Francisco

AU - Sanborn, Rachel E.

AU - Szalai, Zsuzsanna

AU - Ursol, Grigoriy

AU - Mendus, Diana

AU - Wang, Lijia

AU - Wen, Xiaohui

AU - McCleland, Mark

AU - Hoang, Tien

AU - Phan, See

AU - Socinski, Mark A.

N1 - INTRODUCTION: We report the final results of the phase 3 IMpower132 study evaluating atezolizumab plus carboplatin or cisplatin plus pemetrexed (APP) in patients with nonsquamous NSCLC.

PY - 2021/4/1

Y1 - 2021/4/1

UR - https://digitalcommons.psjhealth.org/publications/4789/

U2 - 10.1016/J.JTHO.2020.11.025

DO - 10.1016/J.JTHO.2020.11.025

M3 - Article

VL - 16

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.

Disciplines

Access to Document

Other files and links

Cite this